☆ 4.3 Editorial Material

Nonfasting TG/HDL-C ratio seems a good predictor of MACE in CAD patients with statin therapy. Could it be a treatment target?

JOURNAL OF CARDIOLOGY (2018)

Journal

JOURNAL OF CARDIOLOGY

Volume 71, Issue 1-2, Pages 8-9

Publisher

ELSEVIER SCIENCE BV

DOI: 10.1016/j.jjcc.2017.09.001

Keywords

Nonfasting triglycerides; High-density lipoprotein cholesterol; Cardiovascular events

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.